cyclohexanone has been researched along with curcumin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandramouli, A; Larsen, L; Nelson, MA; Rosengren, RJ; Somers-Edgar, TJ; Taurin, S | 1 |
| Diederich, M; Larsen, L; Rosengren, RJ; Schumacher, M; Somers-Edgar, TJ; Taurin, S; Yadav, B | 1 |
| Gandhy, SU; Kim, K; Larsen, L; Rosengren, RJ; Safe, S | 1 |
| Israf, DA; Lajis, NH; Lee, YZ; Ming-Tatt, L; Sulaiman, MR; Tham, CL | 1 |
| Ao, GZ; Cao, Y; Li, HQ; Ma, H; Xu, YY | 1 |
| Hawkins, BC; Li, Y; Paxton, JW; Revalde, JL; Rosengren, RJ | 1 |
| Abas, F; Abdul Bahari, MN; Ahmad, S; Lajis, NH; Lam, KW; Leong, SW; Mohd Aluwi, MF; Mohd Faudzi, SM; Rullah, K; Shaari, K; Tham, CL | 1 |
| Bugde, P; Hawkins, BC; Li, Y; Paxton, JW; Revalde, JL; Rosengren, RJ; Wijeratne, TS | 1 |
| Alibeiki, F; Jafari, N; Karimi, M; Peeri Dogaheh, H | 1 |
| Abas, F; Ahmad, S; Lai, KS; Nazarudin, NA; Razali, NA | 1 |
| Fuji, S; Kato, H; Limtrakul Dejkriengkraikul, P; Mapoung, S; Naiki-Ito, A; Ovatlarnporn, C; Suzuki, S; Takahashi, S; Yodkeeree, S | 1 |
11 other study(ies) available for cyclohexanone and curcumin
| Article | Year |
|---|---|
Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines.
Topics: Breast Neoplasms; Cell Death; Cell Division; Cell Line, Tumor; Curcumin; Cyclohexanones; Drug Screening Assays, Antitumor; Female; G2 Phase; Heterocyclic Compounds; Humans; Neoplasm Proteins; Receptors, Estrogen; Signal Transduction | 2011 |
Synthesis and cytotoxic potential of heterocyclic cyclohexanone analogues of curcumin.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Curcumin; Cyclohexanones; Female; Heterocyclic Compounds; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; NF-kappa B; Structure-Activity Relationship | 2010 |
Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Curcumin; Cyclin D1; Cyclohexanones; Down-Regulation; ErbB Receptors; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; NF-kappa B; Piperidines; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-met; Reactive Oxygen Species; Repressor Proteins; Sp Transcription Factors | 2012 |
Development and validation of a bioanalytical method for quantification of 2,6-bis-(4-hydroxy-3-methoxybenzylidene)-cyclohexanone (BHMC) in rat plasma.
Topics: Animals; Calibration; Chromatography, High Pressure Liquid; Curcumin; Cyclohexanones; Rats; Reference Standards; Spectrophotometry, Ultraviolet | 2012 |
Design, synthesis and molecular docking of α,β-unsaturated cyclohexanone analogous of curcumin as potent EGFR inhibitors with antiproliferative activity.
Topics: Antineoplastic Agents; Binding Sites; Catalytic Domain; Cell Line, Tumor; Cell Proliferation; Curcumin; Cyclohexanones; Drug Design; ErbB Receptors; Hep G2 Cells; Humans; Molecular Docking Simulation; Protein Kinase Inhibitors; Structure-Activity Relationship | 2013 |
Heterocyclic cyclohexanone monocarbonyl analogs of curcumin can inhibit the activity of ATP-binding cassette transporters in cancer multidrug resistance.
Topics: Animals; ATP-Binding Cassette Transporters; Cell Line, Tumor; Curcumin; Cyclohexanones; Dogs; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; HEK293 Cells; Heterocyclic Compounds; Humans; Insecta; Madin Darby Canine Kidney Cells | 2015 |
Nitric oxide inhibitory activity and antioxidant evaluations of 2-benzoyl-6-benzylidenecyclohexanone analogs, a novel series of curcuminoid and diarylpentanoid derivatives.
Topics: Animals; Antioxidants; Benzylidene Compounds; Cell Survival; Curcumin; Cyclohexanones; Humans; Inhibitory Concentration 50; Macrophages; Mice; Microsomes, Liver; Nitric Oxide; Pentanoic Acids; RAW 264.7 Cells; Structure-Activity Relationship | 2015 |
Curcumin and its cyclohexanone analogue inhibited human Equilibrative nucleoside transporter 1 (ENT1) in pancreatic cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Curcumin; Cyclohexanones; Deoxycytidine; Drug Interactions; Drug Resistance, Neoplasm; Equilibrative Nucleoside Transporter 1; Gemcitabine; Humans; Pancreatic Neoplasms; Uridine | 2017 |
Potent anti-cancer effects of less polar Curcumin analogues on gastric adenocarcinoma and esophageal squamous cell carcinoma cells.
Topics: Adenocarcinoma; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Curcumin; Cyclohexanones; Esophageal Squamous Cell Carcinoma; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Proteins; Stomach Neoplasms | 2017 |
Curcumin derivative, 2,6-bis(2-fluorobenzylidene)cyclohexanone (MS65) inhibits interleukin-6 production through suppression of NF-κB and MAPK pathways in histamine-induced human keratinocytes cell (HaCaT).
Topics: Anti-Inflammatory Agents; Cell Line; Curcumin; Cyclohexanones; Extracellular Signal-Regulated MAP Kinases; Histamine; Humans; Interleukin-6; Keratinocytes; MAP Kinase Signaling System; NF-kappa B | 2018 |
Cyclohexanone curcumin analogs inhibit the progression of castration-resistant prostate cancer in vitro and in vivo.
Topics: Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Curcumin; Cyclohexanones; Disease Progression; Drug Resistance, Neoplasm; Humans; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Recurrence, Local; PC-3 Cells; Prostatic Neoplasms, Castration-Resistant; Xenograft Model Antitumor Assays | 2019 |